CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding CASI Pharmaceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 20 | 23 | +3 |
| Shares | 252.0K | 352.2K | +100.2K (+39.7%) |
| Value | $909.6K | $1.94M | +$1.03M (+112.9%) |
New holders (7)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| VR Adviser, LLC | 111,686 | $614.3K | 0.04% |
| UBS Group AG | 11,321 | $62.3K | 0.00% |
| ADAR1 Capital Management, LLC | 8,240 | $45.3K | 0.01% |
| Royal Bank of Canada | 6,900 | $38.0K | 0.00% |
| Qube Research & Technologies Ltd | 100 | $550 | 0.00% |
| Trust Co of Vermont | 10 | $55 | 0.00% |
| Advisor Group Holdings, Inc. | 8 | $44 | 0.00% |
Sold out (4)
Institutions that held CASI Pharmaceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| FMR LLC | 500 | $1.80K |
| TD Waterhouse Canada Inc. | 300 | $1.03K |
| IFP Advisors, Inc | 40 | $144 |
| Mendota Financial Group, LLC | 20 | $73 |